抗磷脂抗体与首次无诱因静脉血栓栓塞后复发血栓形成
本研究在前瞻性队列中检测307例首次无诱因静脉血栓栓塞患者的抗磷脂抗体,并分析290例因D-二聚体阴性而停用抗凝治疗者的复发血栓风险。结果显示,两次检出同型抗磷脂抗体或检出超过1种抗磷脂抗体类型与复发血栓形成相关,抗磷脂抗体与D-二聚体水平无关联,二者似乎为独立预测因素。
要点
- 检出2或3种不同抗磷脂抗体类型者复发VTE风险比为4.5(95%CI 1.5-13.0;P=.006)。
- 抗磷脂抗体与D-二聚体水平之间无关联。
核心结论
- 在因D-二聚体阴性而停用抗凝治疗的首次无诱因VTE患者中,两次检出同型抗磷脂抗体或检出超过1种抗磷脂抗体类型与复发血栓形成相关。
- 抗磷脂抗体与D-二聚体水平似乎是无诱因VTE患者复发的独立预测因素。
研究设计与样本
- 前瞻性队列研究,纳入307例首次无诱因静脉血栓栓塞患者,间隔约6个月两次检测抗心磷脂抗体、抗β2糖蛋白1抗体和狼疮抗凝物。
- 在290例因D-二聚体阴性结果而停用抗凝治疗的患者中分析抗磷脂抗体与复发血栓形成的关联。
主要发现
- 在25.9%至少1次检出抗磷脂抗体的患者中,复发VTE的风险比为1.8(95%CI 0.9-3.7;P=.09)。
- 在3.8%检出2或3种不同抗磷脂抗体类型(同次或不同次)的患者中,复发VTE的风险比为4.5(95%CI 1.5-13.0;P=.006)。
- 抗磷脂抗体与D-二聚体水平之间无关联。
关键数值与推荐
- 检出2或3种不同抗磷脂抗体类型者复发VTE风险比为4.5(95%CI 1.5-13.0;P=.006)。
- 至少1次检出抗磷脂抗体者复发VTE风险比为1.8(95%CI 0.9-3.7;P=.09)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is uncertain whether antiphospholipid antibodies (APAs) increase the risk of recurrence after a first unprovoked venous thromboembolism (VTE). We tested for anticardiolipin antibodies, anti-β2 glycoprotein 1 antibodies, and lupus anticoagulant on 2 occasions ∼6 months apart in 307 patients with a first unprovoked VTE who were part of a prospective cohort study. We then determined if APAs were associated with recurrent thrombosis in the 290 patients who stopped anticoagulant therapy in response to negative D-dimer results. Compared with those without an APA, the hazard ratios for recurrent VTE were 1.8 (95% confidence interval [CI], 0.9-3.7; P = .09) in the 25.9% of patients with an APA on ≥1 occasions, 2.7 (95% CI, 1.1-.7; P = .03) in the 9.0% of patients with the same APA on 2 occasions, and 4.5 (95% CI, 1.5-13.0; P = .006) in the 3.8% of patients with 2 or 3 different APA types on either the same or different occasions. There was no association between having an APA and D-dimer levels. We conclude that having the same type of APA on 2 occasions or having >1 type of APA on the same or different occasions is associated with recurrent thrombosis in patients with a first unprovoked VTE who stop anticoagulant therapy in response to negative D-dimer tests. APA and D-dimer levels seem to be independent predictors of recurrence in patients with an unprovoked VTE. This trial was registered at www.clinicaltrials.gov as #NCT00720915.
引用
- Kearon C, Parpia S, Spencer FA, et al. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 2018. PMID: 29490924. doi:10.1182/blood-2017-09-805689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。